The slip
PARKINSON RECEIPTno. 15079
30 Oct 2026, 10:21 UTCdopamine neurons, braak
predictionNFIC in dopamine neurons tracks Braak Lewy-body stage
registeredcfedeeabef7d2631
discovery-0.36 p=0.347 n=9
replication-0.53 p=0.143 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.36, p 0.347)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT3a62b86f86ec40031be78429…
follows 3d971cf9625c…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15079: NFIC in dopamine neurons, braak
- power
- full sample -0.46 (p 0.056, n 18), 95% CI -0.76 to +0.01. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.48 (p 0.042, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.54 (p 0.021, n 18). not the mix.
- skeptic
- leave-one-out range -0.59 to -0.39, sign flips 0; without severely affected donors -0.46 (p 0.056, n 18). robust.
- cell type
- strongest in microglia: -0.62 (p 0.0064, n 18) vs -0.46 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NFIC in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up NFIC · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.45 p 0.110 (needs p < 1.5e-4)